Preview

Koloproktologia

Advanced search

Chromoendoscopy and virtual chromoendoscopy for dysplasia screening in patients with ulcerative colitis (systematic review and meta-analysis)

https://doi.org/10.33878/2073-7556-2024-23-2-143-150

Abstract

AIM: to compare the diagnostic informativeness of mucosal dye spraying (chromoendoscopy) (CE) and virtual chromoendoscopy (VCE) in detecting dysplasia in patients with a long history ulcerative colitis (UC).
MATERIALS AND METHODS: a systematic review and meta-analysis of studies comparing the results of the use of CE and VCE for the diagnosis of colitis-associated dysplasia was performed. The following indicators were evaluated: the frequency of patients with endoscopically detected colitis-associated dysplasia and the frequency of endoscopic diagnosis of colitis-associated dysplasia among the total number of identified lesions. The statistical analysis was carried out using the Review Manager software 5.3
RESULTS: the systematic review included 4 studies, analyzing 364 patients in total. In the study groups, there were no statistical differences in patients with endoscopically detected colitis-associated dysplasia and in endoscopic diagnosis of colitis-associated dysplasia among total number of detected colorectal neoplasms (OR = 0.87; 95% CI 0.60–1.27; p = 0.47 and OR = 0.82; 95% CI 0.58–1.18; p = 0.29).
CONCLUSION: meta-analysis could not demonstrate a significant difference between CE and VCE. However, additional studies are needed to recognize the role of VCE in the differentiation of neoplastic and non-neoplastic lesions in patients with UC

About the Authors

O. V. Arkhipova
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation

 Olga V. Arkhipova 

 Salyama Adilya st., 2, Moscow, 123423, Russia 



A. A. Likutov
Ryzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Salyama Adilya st., 2, Moscow, 123423, Russia 

Barrikadnaya st., 2/1-1, Moscow, 125993, Russia



A. A. Ponomarenko
Ryzhikh National Medical Research Center of Coloproctology

 Salyama Adilya st., 2, Moscow, 123423, Russia 



B. A. Vykova
Ryzhikh National Medical Research Center of Coloproctology

 Salyama Adilya st., 2, Moscow, 123423, Russia 



References

1. Nikulina I.V., Zlatkina A.R., Belousova E.A., et al. Assessment of clinical and epidemiological indicators of inflammatory bowel diseases in the Moscow region. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 1997;2:67–71. (In Russ.).

2. Nikolaeva N.N., et al. Epidemiology of ulcerative colitis and Crohn’s disease in the Krasnoyarsk region. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2004;14(5):133. (In Russ.).

3. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology.2006;130:1030–1038. doi: 10.1053/j.gastro.2005.12.035

4. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526 — 535. doi: 10.1136/gut.48.4.526

5. Magro F, et al. European consensus on the histopathology of inflammatory bowel disease. Journal of Crohn’s and Colitis. 2013;7:827–851. doi: 10.1016/j.crohns.2013.06.001

6. Lu X, et al. p53 expression in patients with ulcerative colitis — associated with dysplasia and carcinoma: a systematic meta-analysis. Gastroenterology.2017;17:111. doi: 10.1186/s12876-017-0665-y

7. Shelygin Y.A., Ivashkin V.T., Belousova E.A., et al. Ulcerative colitis (K51), adults. Koloproktologia. 2023;22(1):10–44. (In Russ.) doi: 10.33878/2073-7556-2023-22-1-10-44

8. Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 Mar;114(3):384–413. doi: 10.14309/ajg.0000000000000152

9. Laine L, Kaltenbach T, Barkun A, et al. SCENIC Guideline Development Panel. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148(3):639–651.e28. doi: 10.1053/j.gastro.2015.01.031

10. Maaser C, Sturm A, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn’s and Colitis. 2019;13(2):144–164. doi: 10.1093/ecco-jcc/jjy113

11. Bisschops R, East JE, Hassan C, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline — Update 2019. Endoscopy. 2019;51(12):1155–1179. doi: 10.1055/a-1031-7657 Epub 2019 Nov 11. Erratum in: Endoscopy. 2019 Dec;51(12):C6. PMID: 31711241.

12. Iannone A, Ruospo M, Wong G, et al. Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn’s Disease: A Systematic Review of Randomized Trials. Clin Gastroenterol Hepatol. 2017;15(11):1684–1697.e11. doi: 10.1016/j.cgh.2016.11.021

13. Marion JF, Waye JD, Present DH, et al. Chromoendoscopytargeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008;103:2342 — 2349. doi: 10.1111/j.1572-0241.2008.01934.x

14. Marion JF, Waye JD, Israel Y, et al. Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis. Clin Gastroenterol Hepatol. 2016;14:713–719. doi: 10.1016/j.cgh.2015.11.011 Epub 2015 Dec 2.

15. Brooker JC, Saunders BP, Shah SG, et al. Total colonic dyespray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc.2002;56:333 — 338. doi: 10.1016/s0016-5107(02)70034-5

16. Le Rhun M, Coron E, Parlier D, et al. High resolution colonoscopy with chromoscopy versus standard colonoscopy for the detection of colonic neoplasia: a randomized study. Clin Gastroenterol Hepatol. 2006;4:349–354. doi: 10.1016/j.cgh.2005.12.009

17. Bisschops R, et al. Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitis. Gastrointestinal Endoscopy.2017;86:1100–1106. doi: 10.1016/j.gie.2017.09.024

18. Bisschops R, et al. Chromoendoscopy versus narrow band imaging in UC: A prospective randomised controlled trial. Gut. BMJ Group. 2018;67(6):1087–1094. doi: 10.1136/gutjnl-2016-313213

19. Pellisé M, et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointestinal Endoscopy. 2011;74(4):840–848. doi: 10.1016/j.gie.2011.05.013

20. WHO Classification of Tumours, 5th Edition, Volume 1. WHO Classification of Tumours Editorial Board, 2019. ISBN-13

21. González-Bernardo O, Riestra S, Vivas S, et al. Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study. Inflamm Bowel Dis. 2021;27(8):1256–1262. doi: 10.1093/ibd/izaa291

22. Efthymiou M, et al. Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease. Inflammation Bowel Diseases.2013;19(10):2132–2138. doi: 10.1097/MIB.0b013e31829637b9

23. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanations and elaboration. BMJ [Internet]. 2009;339:2700. doi: 10.1136/bmj.b2700

24. Higgins JP, Altman DР, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Br. Med. J. 2011;343:889–893. doi: 10.1136/bmj.d5928

25. Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45. doi: 10.1186/1471-2288-14-45

26. Kudo S, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointestinal Endoscopy.1996;44:8–14. doi: 10.1016/s0016-5107(96)70222

27. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo carmine-assisted high magnification chromoscopic colonoscopy for the detection and characterization of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy. 2005;37:1186–1192. doi: 10.1055/s-2005-921032

28. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer inulcerative colitis. Gastroenterology. 2003;124:880 — 888. doi: 10.1053/gast.2003.50146

29. Sano Y, et al. Meshed capillary vessels by use of narrowband imaging for differential diagnosis of small colorectal polyps. Gastrointestinal Endoscopy.2009;69(2):278–283. doi: 10.1016/j.gie.2008.04.066

30. Sano Y, Tanaka S, Kudo SE, et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc. 2016 ;28(5):526–533. doi: 10.1111/den.12644 Epub 2016. PMID: 26927367.

31. Kawasaki K, Nakamura S, Esaki M, et al. Clinical usefulness of magnifying colonoscopy for the diagnosis of ulcerative colitisassociated neoplasia. Dig Endosc.2019;31(1):36–42. doi: 10.1111/den.13382 PMID: 30994234.


Review

For citations:


Arkhipova O.V., Likutov A.A., Ponomarenko A.A., Vykova B.A. Chromoendoscopy and virtual chromoendoscopy for dysplasia screening in patients with ulcerative colitis (systematic review and meta-analysis). Koloproktologia. 2024;23(2):143-150. https://doi.org/10.33878/2073-7556-2024-23-2-143-150

Views: 574


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7556 (Print)
ISSN 2686-7303 (Online)